All lobbying filings
LEAVITT PARTNERS, LLC
Lobbying for SAVE RARE TREATMENTS TASK FORCE · Dedicated to restoring the spirit of R&D incentives in the Orphan Drug Act.
Filing
3rd Quarter - Report
Lobbying activity
1
Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain excluded so long as their FDA approved uses are exclusively for rare diseases.